Many productive years in the biologics industry have produced many accomplishments in vaccine design, implementation, testing and acceptance.
1. Scale-up of recombinant bacterial and viral vectors. Most recently Sylvatic Plague -Raccoonpox virus. 2. New live bacterial and viral stabilizers. 3. New growth implementation for virus-bearing cell cultures. 4. BSL-2 and BSL-3 lab design and oversight. 5. ABSL-2 audits and CAPA. 6. New challenge models for livestock and laboratory animals. 7. DSP for recombinantly expressed proteins. 8. International regulatory interactions. 9. Improved vaccines for African livestock.